Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study-Reference-Cited by-同舟云学术

Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study

Published:2015-10 Issue:4 Volume:160 Page:725-731.e1
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Prenner Jonathan L.,Halperin Lawrence S.,Rycroft Catherine,Hogue Susan,Williams Liu Zinaria,Seibert Robert

Publisher

Elsevier BV

Subject

Ophthalmology

Reference19 articles.

1. World Health Organisation. Priority eye diseases: age-related macular degeneration. 2013. Available at http://www.who.int/blindness/causes/priority/en/index8.html#. Accessed June 11, 2015.

2. Prevalence of age-related macular degeneration in the United States;Friedman;Arch Ophthalmol,2004

3. Quality of life in age-related macular degeneration: a review of the literature;Mitchell;Health Qual Life Outcomes,2006

4. The burden of age-related macular degeneration: a value-based medicine analysis;Brown;Trans Am Ophthalmol Soc,2005

5. Association of vision loss in glaucoma and age-related macular degeneration with IADL disability;Hochberg;Invest Ophthalmol Vis Sci,2012

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I Study of Tivozanib Eye Drops in Healthy Volunteers and Patients with Neovascular Age-Related Macular Degeneration;Ophthalmology Science;2024-11

2. Emerging Oral Pharmaceuticals for Dry Age-Related Macular Degeneration: Mechanism of Action, Current Clinical Status, and Future Directions;Ophthalmic Surgery, Lasers and Imaging Retina;2024-09

3. Faricimab in Previously Treated Eyes With Neovascular Age-Related Macular Degeneration: An Assessment of Durability and Treatment Outcomes;Ophthalmic Surgery, Lasers and Imaging Retina;2024-09

4. Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration;Ophthalmology Retina;2024-08

5. Long-acting delivery and therapies for neovascular age-related macular degeneration;Expert Opinion on Biological Therapy;2024-07-22